GetRelief Rx review

Nobody will tell you what a quarter dose costs here. The price card carries "(pricing dependent on dosing)" right beside its figure, which is honest and useless in the same breath: the direction is stated, the ladder is not. That matters more here than almost anywhere, because low, steady dosing is the pitch — this is a daily sublingual product sold on the argument that you should not automatically climb to maintenance levels. Give it credit for what it does publish: a full list of the 34 states and Washington DC it serves, the medical director by name, and the whole subscription total beside every per-month figure. Two things will cost you if you misread them. There is no monthly plan at all, so the smallest purchase is two months charged together. And nothing on the site addresses whether a sublingual GLP-1 absorbs the way an injected one does.

Vs median

$34/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Check plan terms

GetRelief Rx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

GetRelief Rx sells semaglutide and tirzepatide as a daily sublingual suspension rather than a weekly injection — "Not a Shot. Not a Tablet" — and positions the product explicitly around microdosing: "lower, steady dosing rather than automatically increasing to higher maintenance levels". It publishes a full list of the 34 states and Washington DC it serves, names its medical director, and sells only two-month and six-month subscriptions. The operating entity is Get Relief RX LLC in Billings, Montana. Prices are quoted as starting figures the site says depend on your dose, and the ladder behind them is not published.

THE DOSE-TO-PRICE LADDER IS NOT PUBLISHED. The card says pricing depends on dosing and then quotes one figure, so what a low dose actually costs cannot be worked out before you pay

• THERE IS NO MONTHLY PLAN. One page labels its cards "Monthly Plan Options", but every product is sold as a two-month or six-month subscription — the minimum commitment is two months and $418
• Sublingual absorption of semaglutide and tirzepatide is not addressed anywhere on the site, and no supporting data is cited for the route
• The navigation offers a "Medications & Pricing" section that leads to the site's own "Page Not Found"
• Product copy is mixed between molecules — the semaglutide listing includes a benefit written for dual GIP/GLP-1 therapy, and two benefit tiles are word-for-word identical across both drugs
• The compounding pharmacy is not named; the footer lists "GetRelief Pharmacy" as a partner without saying whether it is in-house or a third party
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

GetRelief Rx is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan